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G-protein heterotrimers, composed of a guaninenucleotide-binding
Gα subunit and an obligate Gβγ dimer, regulate signal transduction
pathways by cycling between GDP- and GTP-bound states. Signal
deactivation is achieved by Gα-mediated GTP hydrolysis (GTPase
activity) which is enhanced by the GTPase-accelerating protein
(GAP) activity of “regulator of G-protein signaling” (RGS) proteins.
In a cellular context, RGSproteins have also been shown to speedup
theonsetof signaling,andtoacceleratedeactivationwithoutchang-
ing amplitude or sensitivity of the signal. This latter paradoxical
activity has been variably attributed to GAP/enzymatic or non-
GAP/scaffolding functions of these proteins. Here, we validated
and exploited a Gα switch-region point mutation, known to engen-
der increasedGTPaseactivity, tomimic in cis theGAP functionofRGS
proteins.While the transition-state, GDP·AlF4
−-bound conformation
of the G202Amutant was found to be nearly identical to wild-type,
Gαi1(G202A)·GDP assumed a divergent conformation more closely
resembling theGDP·AlF4
−-bound state.When placedwithin Saccha-
romyces cerevisiae Gα subunit Gpa1, the fast-hydrolysis mutation
restored appropriate dose–response behaviors to pheromone sig-
naling in the absence of RGS-mediated GAP activity. A biolumines-
cence resonance energy transfer (BRET) readout of heterotrimer
activation with high temporal resolution revealed that fast intrinsic
GTPase activity could recapitulate in cis the kinetic sharpening
(increased onset and deactivation rates) and blunting of sensitivity
also engendered by RGS protein action in trans. Thus Gα-directed
GAP activity, thefirst biochemical function ascribed to RGS proteins,
is sufficient to explain the activation kinetics and agonist sensitivity
observed from G-protein–coupled receptor (GPCR) signaling in a
cellular context.
bioluminescence resonance energy transfer | GTPase-accelerating protein
activity | Regulator of G-protein Signaling proteins | signal onset and
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Heterotrimeric Gproteins regulatenumerous signalingpathwaysthat elicit critical physiological responses in many organisms
from Dictyostelium and fungi to plants and metazoans (1–3). The
G-protein heterotrimer consists of a guanine nucleotide-binding Gα
subunit that, in its GDP-bound state, is tightly associated with an
obligateGβγ dimer (4, 5). Agonist binding to seven-transmembrane,
G-protein–coupled receptors (GPCRs) activates this complex by
catalyzing exchange of GDP for GTP in Gα that leads to a con-
formation change andGβγ dissociation (6–8). Proper responses rely
on timelydeactivationofheterotrimer signaling, achievedby intrinsic
Gα-mediated hydrolysis of GTP to GDP (GTPase activity). This
hydrolysis is enhanced by “regulator of G-protein signaling” (RGS)
proteins that serve as GTPase-accelerating proteins (GAPs) (9, 10).
The RGS domain common to these proteins elicits GAP activity
by stabilizing Gα in its transition-state intermediate form, thus low-
ering the required reaction free energy for GTP hydrolysis and
subsequent return to the Gα·GDP state (11, 12).
Early studies of the cellular effects of RGS proteins on GPCR
signaling described accelerated signal onset as well as accel-
erated decay, particularly for Gβγ-gated ion channel responses
measured by whole-cell electrophysiological recordings, as
reviewed elsewhere (13). For example, the slow, non-
physiological rate of K+ current onset, normally seen with
inward-rectifying potassium (GIRK/Kir3) channels expressed in
heterologous systems (CHO-K1 cells, Xenopus oocytes), was
dramatically sharpened upon coexpression of RGS proteins such
as RGS4 and RGS8. Surprisingly, no demonstrable changes in
signal amplitude nor agonist sensitivity were apparent in these
early reports (14, 15). Both groups labeled these findings para-
doxical (14, 15) in light of the negative regulatory role first
ascribed to RGS proteins (i.e., Gα-directed GAP activity).
Models have been put forth to account for this “paradoxical”
regulatory role of RGS proteins in GPCR signaling. Many RGS
proteins have multiple, modular protein domains in addition to
the signature RGS domain, as previously reviewed (9, 16). Thus,
a model of “physical scaffolding” (17, 18) suggests that RGS
proteins use these accessory protein domains (and/or non-GAP
motifs within the RGS domain) to mediate interactions that
modulate receptor/heterotrimer coupling or other aspects of
receptor/G-protein/effector signaling output (19). Alternatively,
the “kinetic scaffolding” or “spatial focusing” (20) model
eschews evoking additional functions for RGS proteins and relies
on their GAP activity alone. This model suggests that G-protein
activation becomes saturated near spatially constrained “clus-
ters” of agonist-activated GPCRs, causing GTP hydrolysis, rather
than GDP release, to become rate limiting in the nucleotide
cycle. RGS domain GAP activity is proposed to enhance steady-
state pathway activation by preventing local depletion of
Gα·GDP, thus providing receptors with additional Gαβγ hetero-
trimers to activate. Therefore, by promoting continuous cycling
of G-protein activity, as opposed to prolonging the Gα·GTP
state, rapid GTP hydrolysis alone may provide a mechanism of
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accelerating both signal onset and decay and shaping signal
sensitivity (19–21).
We sought evidence from whole-cell GPCR signaling that
could distinguish the contribution(s) of GAP and non-GAP
functions of RGS proteins to the observations of accelerated
kinetics, yet paradoxical lack of amplitude or sensitivity changes,
attributed to RGS proteins. Our strategy was to impose the
structural and functional changes in Gα brought about by RGS
protein binding that enhance GTP hydrolysis, while avoiding
other possible consequences of RGS protein binding (e.g.,
physical scaffolding). We used a Gα switch II point mutation
(G202A in human Gαi1, G203A in human GαoA, G321A in
Saccharomyces cerevisiae Gpa1) previously found to increase
greatly the intrinsic rate of GTP hydrolysis (22). Our structural
models obtained by x-ray crystallography show that the glycine-
to-alanine substitution promotes a pretransition state mimicked
by the Gα·GDP·AlF4− complex (23), i.e., the same state most
favored for RGS protein binding (11, 24). Placing this fast-
GTPase mutation into the Gα integral to yeast pheromone
sensing was sufficient to restore wild-type dose-responsive
behavior in the absence of RGS domain GAP activity. Recon-
stituting neurotransmitter receptor signaling with fast-GTPase
Gα accelerated both signal onset and decay and blunted sensi-
tivity. This study thus provides experimental evidence that faster-
than-wild-type GTP hydrolysis by Gα, whether accomplished via
RGS protein GAP activity in trans or via accelerated intrinsic
GTPase activity in cis, is sufficient to support rapid signal onset
and altered sensitivity of agonist activation of GPCRs.
Results
Structures of Gαi1(G202A) Mutant Reveal a Pretransition State for
GTP Hydrolysis. A glycine-to-alanine mutation at position 202 of
the Gαi1 switch II region was originally identified as increasing
the intrinsic GTPase activity at least 10-fold in vitro (22). We
confirmed this enhanced GTPase activity in single-turnover
[γ-32P]GTP hydrolysis assays (Fig. 1A). RGS domains not only
accelerate wild-type Gα GTPase activity, but also preferentially
bind their transition-state mimetic form (Gα·GDP·AlF4−) over
the ground state (Gα·GDP) (24). Therefore, evidence of negli-
gible RGS4-mediated enhancement of GTPase rate as well as
increased RGS4 affinity for Gαi1(G202A)·GDP (KD 18 μM) vs.
wild-type Gαi1·GDP (KD 430 μM) led Thomas et al. (22) to
hypothesize that the G202A mutant, like RGS domain-bound
Gα, is stabilized in a pretransition state for GTP hydrolysis,
explaining its enhanced intrinsic GTPase activity. Here, to
ascertain the structural determinants of enhanced GTP hydrol-
ysis, we established structural models derived from x-ray crys-
tallography for the GDP- and GDP·AlF4
−-bound forms of
Gαi1(G202A) to 2.6 Å and 2.42 Å resolution, respectively; data
collection and refinement statistics are listed in Table S1, and
illustrations of model fit to experimental electron density are
presented in Fig. S1.
Previous Gα structures, reviewed elsewhere (5, 7, 25), have
detailed the conformational changes that three switch regions
undergo during transition between GTP- and GDP-bound states.
Key catalytic residues have also been identified, including a
phosphate-neutralizing arginine and magnesium-coordinating
threonine in switch-I (R178 and T181 in Gαi1), and a water-
coordinating glutamine in switch II (Q204 in Gαi1). The side
chains of these three residues are observed in their hydrolysis-
coordinating roles within the structure of Gαi1 bound to GDP
and to the planar ion AlF4
−, which induces a stable, transition-
state mimetic form (PDB id 1GFI, ref (23); Fig. 1B). The
GDP·AlF4
−-bound conformation of the G202A mutant is nearly
identical to wild-type Gαi1·GDP·AlF4− (overall RMSD 0.93 Å;
Fig. S2), with only slight alterations in the three switch regions.
Minor displacements in both the β2/α2 loop and switch I likely




Fig. 1. G202A substitution in Gαi1 switch II leads to a pretransition state
that accelerates intrinsic GTPase activity. (A) Single-turnover GTP hydrolysis
assays were performed on ice using indicated recombinant wild-type and
mutant Gα proteins, demonstrating the enhanced intrinsic GTPase rate of
the Gαi1(G202A) mutant. The nearly order-of-magnitude GTPase rate
enhancement observed with the G202A mutation is consistent with that
reported by Thomas et al. (22); nevertheless, it must be acknowledged that
some RGS proteins have been observed to accelerate Gα-mediated GTP
hydrolysis by orders of magnitude under optimal conditions (24, 45). (B)
Ribbon Cα tracing of the proposed transition state for GTP hydrolysis from
the published structural model of wild-type Gαi1·GDP·AlF4− (PDB id 1GFI;
(23), highlighting the disposition of the three residues involved in GTP
hydrolysis (Arg-178, Thr-181, Gln-204; yellow sticks), as well as the position of
glycine-202 (red). GDP is colored magenta with the AlF4
− and magnesium
ions colored teal and green, respectively. (C) Ribbon Cα tracing of our 2.6 Å
structural model of GDP-bound Gαi1(G202A) derived from x-ray crystallog-
raphy (PDB id 2PZ2). Switch regions (SI-SIII) are colored red, with the catalytic
residues Arg-178, Thr-181, and Gln-204 depicted in red sticks and the mutant
alanine-202 residue in black sticks.









additional methyl side chain of alanine. Despite these minor
displacements, each of the catalytic residues (R178, T181, Q204)
in Gαi1(G202A)·GDP·AlF4− adopts an orientation similar to
wild-type Gαi1·GDP·AlF4− (i.e., an orientation fully competent
for GTP hydrolysis).
Conversely, GDP-bound Gαi1(G202A) assumes a divergent
conformation from that of wild-type Gαi1·GDP. In the GDP-
bound state, switch II and switch III are normally unstructured
and highly disordered when observed in crystal structures (26,
27); it is Gα activation, such as by GTP binding or addition of
AlF4
−, that normally elicits structural order in the switch regions,
including switch II adopting a rigid, α-helical conformation and
switch III being suitably stabilized for visualization (23, 28). In
contrast, GDP-bound Gαi1(G202A) displayed sufficient struc-
tural order and suitable electron density to model all three switch
regions (e.g., Fig. 1C and Fig. S1A). Switch regions I and II of
Gαi1(G202A)·GDP are strikingly similar to their conformation in
the GDP·AlF4
−-bound state of both wild-type and G202A Gαi1,
although minor alterations can be noted. Switch I does not
approach the nucleotide-binding pocket as dramatically as in
wild-type Gαi1·GDP·AlF4− (Fig. S2); as previously stated, this
may be in part due to the methyl side-chain of Ala-202 sterically
hindering such a conformation. The catalytic R178 and T181
residues within switch I are, however, positioned similar to the
wild-type Gαi1·GDP·AlF4− structure (cf. Fig. 1 B vs. C; Fig. S2B).
Whereas the switch II β3/α2 loop adopts a conformation some-
what distinct from wild-type Gαi1·GDP·AlF4−, the catalytic Q204
residue is oriented toward nucleotide similar to the orientation
seen in wild-type Gαi1·GDP·AlF4− (Fig. 1B). Together with the
orientations of R178 and T181, this observation suggests that the
G202A mutation causes allosteric conformational changes within
Gα that orient key catalytic residues poised for GTP hydrolysis
even when GDP-bound, confirming the hypothesis (22) that the
G202A mutant is in a “pretransition” state resembling the
changes brought about RGS domain binding (11, 29). Notwith-
standing these structural changes to key catalytic residues, the
G202A mutation did not appreciably affect the affinity of the
GDP-loaded Gαi1 subunit for the Gβγ dimer (Fig. S3).
Glycine to Alanine Substitution in Switch II Accelerates Yeast Gpa1
GTPase Activity and Restores Wild-Type Pheromone Sensitivity to
RGS-Insensitive Yeast.Mating pheromone signaling in S. cerevisiae
was one of the first signaling pathways shown to be regulated by
an RGS protein (1, 30), with the yeast RGS protein Sst2 now
well established as the principal trans-regulator of the pher-
omone response (31). Only one Gα subunit, Gpa1, is coupled to
the yeast pheromone receptor, and it is highly similar to mam-
malian Gαi1, including a nearly identical switch II (Fig. S4A). A
“RGS-insensitivity” point mutation within switch I of Gα was
first identified in S. cerevisiae (namely, Gpa1G302S) (32); this
mutation renders Gα insensitive to RGS domain GAP activity,
but leaves unaffected its capacity for intrinsic GTP hydrolysis
and coupling to Gβγ, receptors, and effectors (32, 33).
We first established that the fast-hydrolysis switch II mutation
functions similarly in yeast Gpa1 (i.e., G321A). Single-turnover
GTPase assays with recombinant Gpa1 demonstrated enhanced
intrinsic GTPase activity for Gpa1(G321A) of at least 16-fold
over wild-type (Fig. S4B); this rate enhancement was similar to
that provided to wild-type Gpa1 by the RGS domain of Sst2.
To assess the effect of enhanced intrinsic GTP hydrolysis on
receptor-mediated signaling, pheromone response assays
were carried out in a-haploid S. cerevisiae strains in which
the wild-type GPA1 locus was replaced (via homologous re-
combination) with Gpa1 point mutants: either Gpa1G321A
to provide faster-than-wild-type GTP hydrolysis, Gpa1G302S to
render the protein RGS-insensitive, or Gpa1G302S/G321A
to provide both activities. A pheromone pathway-specific lacZ
reporter gene was used to assess dose-dependent changes in
α-factor pheromone-induced transcriptional up-regulation (Fig.
2); pheromone signaling was independently measured using a
“halo assay” (Fig. S5) indicative of pheromone-dependent
growth inhibition (34, 35). Expression of RGS-insensitive
Gpa1G302S led to a leftward-shifted pheromone dose–response
curve, as well as larger halos and greater basal activity (Fig. 2
Inset; Fig. S5A), consistent with its original discovery as a
“supersensitive allele” of Gpa1 (32) and demonstrating that
endogenous Sst2 acts to decrease the sensitivity of pheromone
receptor signaling through Gpa1. In contrast, expression
of the fast-GTPase Gpa1G321A resulted in no change in
basal activity or pheromone sensitivity, although a statistically
significant, ∼20% decrease in maximal efficacy was noted
(as also observed with the G302S allele) (Fig. S5C). Addition
of faster-than-wild-type hydrolysis to the RGS-insensi-
tive Gpa1 mutant (i.e., Gpa1G302S/G321A) was observed
to supersede the effect of RGS-insensitivity in restoring wild-
type basal activity and pheromone sensitivity (i.e., EC50),
as well as the ultrasensitive nature of the response (i.e., Hill
slope >1) (Fig. 2 and Fig. S5). Thus, the glycine-to-alanine
fast hydrolysis mutation phenocopied the effects of the RGS
protein Sst2 on agonist sensitivity.
Glycine to Alanine Substitution in Switch II Restores Neurotransmitter
Signaling Kinetics and Sensitivity to RGS-Insensitive GαoA. To
determine the effect of accelerating hydrolysis on GPCR sig-
naling in mammalian cells, we used HEK 293 cells transiently
expressing the D2 dopamine receptor (D2R) that couples to
pertussis toxin (PTX)–sensitive Gαi/o proteins. Coupling to
endogenous Gi/o heterotrimers was blocked by PTX pretreat-
ment, and D2R signaling was reconstituted by expressing PTX-
insensitive GαoA C351G. To measure GαoA activation, we used a
recently developed bioluminescence resonance energy transfer
(BRET) assay (36), wherein Gβγ dimers labeled with the YFP
variant Venus (Gβ1γ2-V) are liberated by active Gα subunits and
bind to a Renilla luciferase-labeled, membrane-associated C-
terminal fragment of GRK3 (masGRKct-Rluc8). Energy transfer
Fig. 2. The glycine-to-alanine switch II mutation Gpa1G321A restores wild-
type pheromone sensitivity to RGS-insensitive yeast. Strain BY4741 of S.
cerevisiae was transformed with integrating plasmids (pRS406) containing
Gpa1WT, Gpa1G302S, Gpa1G321A, or Gpa1G302S/G321A as well as a plasmid
(pRS423 FUS1-lacZ) containing the pheromone-inducible FUS1 promoter and
lacZ reporter. Yeast grown to midlog growth phase were treated with the
indicated concentrations of α-factor, and the resulting β-galactosidase
activity was measured by fluorescence spectrophotometry. In the time frame
of α-factor treatment and subsequent transcriptional readout (90 min), the
yeast RGS protein Sst2 is induced (1). Data shown are the results of three
independent experiments using multiple colonies (WT, n = 14; G302S, n = 14;
G321A, n = 9; G302S/G321A, n = 13) performed in triplicate. Error bars, ±SE.
(Inset) A similar transcriptional reporter experiment was conducted, but
yeast were left untreated to measure basal β-galactosidase activity.
7068 | www.pnas.org/cgi/doi/10.1073/pnas.0912934107 Lambert et al.
between masGRKct-Rluc8 and Gβ1γ2-V provides a biosensor of
G-protein heterotrimer activation amenable to both steady-state
measurements and time-resolved kinetic experiments (36).
D2R activation with the agonist quinpirole (10−10–10−5 M)
produced a graded increase in BRET between masGRKct-Rluc8
and Gβ1γ2-V (Fig. 3A). In cells expressing PTX-insensitive GαoA,
referred to here as wild-type (wt), the EC50 for this response
was 405 ± 49 nM (n = 12). Agonist sensitivity was increased
for responses mediated by RGS-insensitive GαoA G184S
(EC50 = 90 ± 12 nM; n = 12; Fig. 3A), suggesting that endog-
enous RGS proteins decrease agonist sensitivity in HEK 293
cells. Conversely, overexpression of RGS8 decreased agonist
sensitivity even further (EC50 = 2.4 ± 0.4 μM; n = 8; Fig. 3A),
suggesting that wt Gα subunits are not saturated by endogenous
RGS proteins. When the RGS insensitivity and fast hydrolysis
mutations were combined (GαoA G184S/G203A), RGS insensi-
tivity was preserved (Fig. S6), and yet the fast hydrolysis phe-
notype prevailed. Increased agonist sensitivity observed with the
RGS insensitivity mutation alone was reversed by adding the fast
hydrolysis mutation (EC50 = 1.2 ± 0.1 μM; Fig. 3A). Responses
to saturating concentrations of quinpirole were increased fur-
ther by addition of hydrolysis-resistant GTPγS (Fig. 3C), indi-
cating that the reporter of heterotrimer activation (masGRKct-
Rluc8) was not saturated and, thus, the maximum response
should be sensitive to changes in Gα GTPase rate. Indeed, when
compared with responses mediated by either wt GαoA or RGS-
insensitive GαoA subunits, maximum responses after RGS8
overexpression and for RGS-insensitive/fast hydrolysis double
mutants were significantly decreased (P < 0.01; repeated-
measures ANOVA; Fig. 3C). Importantly, maximal responses
were equally blunted when GTP hydrolysis was accelerated by
saturating RGS8 or by the fast hydrolysis mutation (P > 0.05;
Fig. 3C). These results are thus consistent with those observed
for yeast pheromone signaling, and indicate that changes in Gα
GTPase rate in both systems produce shifts in agonist sensitivity
and response amplitude.
We then took advantage of the ability of the BRET assay to
indicate rapid changes in heterotrimeric G-protein activity to
examine rates of response onset and recovery mediated by these
GαoA mutants. BRET between Gβ1γ2-V and masGRKct-Rluc8
was monitored during sequential addition of saturating concen-
trations of quinpirole (30 μM) and the antagonist haloperidol
(10 μM). Both the onset and recovery of responses mediated by
RGS-insensitive GαoA G184S subunits were slowed when com-
pared with wild-type (P < 0.01; n = 3–12 performed in quad-
ruplicate; Fig. 3B), as seen previously in numerous cell types (37,
38). In contrast, overexpression of RGS8 accelerated both onset
and recovery of responses mediated by wt GαoA, again suggesting
endogenous RGS proteins do not saturate these subunits (Fig. 3
B, D, and E). Once again, when the RGS insensitivity and fast
hydrolysis mutations were combined, fast hydrolysis compen-
sated for RGS insensitivity. Both response onset and recovery
mediated by G184S/G203A double mutant subunits were sig-
nificantly faster than those observed with wild-type GαoA or
RGS-insensitive GαoA (P < 0.01; Fig. 3 B, D, and E), and were
indistinguishable from those observed with RGS8 overexpression
(P > 0.05; Fig. 3 D and E). Similar effects were observed using
analogous PTX-insensitive Gαi1 mutants in reconstituted sig-
naling by the M4 muscarinic acetylcholine receptor, i.e., the fast
hydrolysis mutation compensated for the loss of RGS sensitivity
(Fig. S7 and Table S2). In this case, agonist (carbachol) sensi-
tivity was less affected by changes in hydrolysis, similar to pre-
vious reports with native PTX-sensitive Gα subunits (14, 15).
Taken together, these results indicate that accelerating GTP
hydrolysis with a mutation that promotes a pretransition state for
GTP hydrolysis reproduces the effects of RGS protein binding
on agonist sensitivity and kinetics in mammalian cells.
Discussion
The discovery of RGS proteins resolved a longstanding dis-
crepancy between the slow intrinsic GTPase rate of Gα subunits
seen in vitro and rapid termination of heterotrimeric G-protein





Fig. 3. The glycine-to-alanine switch II mutation G203A restores rapid
onset and recovery kinetics, as well as steady-state agonist sensitivity, to
responses mediated by RGS-insensitive GαoA in HEK 293 cells. (A) Increases in
BRET (ΔBRET) between masGRKct-Rluc8 and Gβ1γ2-V upon dopamine D2R
activation are plotted against the concentration of the agonist quinpirole.
Cells were pretreated with pertussis toxin (PTX) to inactivate native Gαi/o
subunits, and responses were mediated by PTX-insensitive GαoA subunits:
wild-type (wt), RGS-insensitive (G184S), or RGS-insensitive/fast hydrolysis
double mutant (G184S/G203A; GS/GA). “+ RGS8” denotes ectopic over-
expression of RGS8 in cells coexpressing PTX-insensitive, wt GαoA. Responses
are normalized to the maximum response elicited by wt GαoA in the absence
of RGS8 overexpression. (B) Normalized BRET between masGRKct-Rluc8 and
Gβ1γ2-V is plotted against time during sequential addition of quinpirole (30
μM) and haloperidol (10 μM) for each of the GαoA variants. Traces represent
the mean of 9–11 experiments, and are normalized to the response imme-
diately before addition of haloperidol. (C) Maximal responses, elicited by
saturating quinpirole (33 μM; “quin”) normalized to the responses elicited
by permeabilization and addition of GTPγS, are plotted for the same four
GαoA variants; n = 5, performed in quadruplicate; n.s., P > 0.05. (D) Average
onset time constants (τ onset) plotted for each of the GαoA variants (± SEM,
n = 5–12, performed in quadruplicate). (E) Average recovery time constants
(τ recovery) plotted for each of the GαoA variants (±SEM, n = 3–10, per-
formed in quadruplicate); n.s., P > 0.05; for C–E, all pairwise comparisons not
marked “n.s.” were significantly different (P < 0.05, ANOVA).









strating this important role of RGS proteins for timely response
termination (14, 15) described new puzzling observations. By
increasing the rate of GTP hydrolysis, RGS proteins were
expected to speed response recovery, and this expectation was
fulfilled. It was also expected that accelerating GTP hydrolysis
would decrease steady-state agonist sensitivity, but this was not
observed (14, 15). It appeared that the reason for the maintained
agonist sensitivity in these studies was an unexpectedly large
increase in the rate of response onset. The authors of these
studies concluded that RGS proteins increased not only the rate
of G-protein deactivation, but also the rate of G-protein acti-
vation, the latter so much so that agonist sensitivity and response
amplitude were left unchanged (14, 15).
Two primary models have been proposed to account for RGS-
protein–mediated acceleration of response onset. The first of these
stems from the observation that RGS proteins can interact directly
or indirectly with GPCRs in addition to G proteins, as reviewed
elsewhere (16, 18, 41). Thus RGS proteins might facilitate GPCR
coupling to G proteins by directly promoting their physical inter-
action, i.e., by serving as physical scaffolds. The second model is
similar to that originally proposed for activation of theGαq-effector
and -GAP protein PLCβ (42), and suggests that rapid hydrolysis
allows for rapid reactivation ofGα by active receptor (9, 19, 20, 43).
Such a mechanism could promote coupling by reducing the need
for GPCRs and G proteins to associate by slow diffusion and col-
lision events. The positive effect of RGS proteins because of this
kinetic scaffolding mechanism would depend entirely on accel-
eration of GTP hydrolysis. A third potential mechanism, GAP-
mediated enhancement of receptor-stimulated GDP release, was
proposed recently based on modeling studies incorporating steady-
state GTPase activity (19). Experimental data consistent with these
models have been reported (17, 20, 44, 45). However, little exper-
imental evidence was previously available to directly support or
exclude any mechanism.
In the present study, we show that a mutation that imposes a
pretransition state and accelerates GTP hydrolysis mimics the
influence of RGS proteins on response kinetics and agonist sen-
sitivity. Therefore, theGAP function of RGS proteins is sufficient
to explain both the increase in the rate of deactivation and
(independently) the rate of response onset. Our study leaves the
underlying mechanism for this independent acceleration of
response onset unresolved and thus our understanding of the
GAP function of RGS proteins remains incomplete. Our findings
are generally consistent with, but do not definitively establish, a
kinetic scaffolding model and/or other positive regulatory mech-
anisms that depend only on structural changes in Gα. Fur-
thermore, our results do not exclude the possibility that RGS
proteins may also serve as physical scaffolds, perhaps as a means
of achieving receptor-selective regulation (18, 46). However, our
results do imply that physical scaffolding or other non-GAP
functions of RGS proteins are not necessary to explain the effects
of RGS proteins on response kinetics or agonist sensitivity.
Materials and Methods
Protein Purification, Single Turnover GTPase Assays, and Structure Deter-
minations. Recombinant Gpa1 (aa 39–472) and Sst2 RGS domain (aa 408–698)
were each subcloned with N-terminal His6- and TEV-cleavage sites in a
modified pET expression vector (Novagen). His6/TEV-tagged human Gαi1,
both wild-type and G202A mutant, and the two yeast proteins were sepa-
rately purified from clarified Escherichia coli lysate using sequential Ni-NTA
affinity, TEV cleavage, anion exchange, and size-exclusion chromatographies
essentially as previously described (47). Single-turnover GTPase assays using
recombinant Gα subunits were conducted essentially as described previously
(48, 49). For crystallization experiments, purified Gαi1(G202A) protein was
concentrated to 10 mg/mL and stored in crystallization buffer (50 mM Hepes
pH 8, 5 mM DTT, 1 mM EDTA, 1 mM MgCl2, and 100 μM GDP) with or
without added AlCl3 (30 μM) and NaF (10 mM). Details of crystal growth and
structure determinations are presented in SI Materials and Methods.
Pheromone Transcriptional Reporter Assay and Halo Assay of Growth Inhibition.
Standard methods for manipulating S. cerevisiae expression plasmid DNA
and the growth, maintenance, and transformation of yeast were used
throughout, as previously described (34, 35). Yeast strains bearing inte-
grated gpa1 mutation(s), created by homologous recombination and vali-
dated by PCR as described in SI Materials and Methods, were transformed
with the transcriptional reporter plasmid pRS423 FUS1-lacZ, and β-gal-
actosidase activity was determined as described elsewhere (34, 35). The
pheromone-induced growth inhibition assay has also been described pre-
viously (50).
BRET Measurements. Agonist-dependent cellular measurements of bio-
luminescence resonance energy transfer betweenmasGRKct-Rluc8 and Gβ1γ2-
V were performed as previously described (36). Details, including curve-
fitting examples (Fig. S8), are available in SI Materials and Methods.
ACKNOWLEDGMENTS. We thank Dr. Henrik G. Dohlman (UNC) for advising
on the yeast work by S.D.C., Ryan Shanks for initial input into the project,
and Dr. Jason Snyder of the UNC Protein Core for the ΔN38-Gpa1 expression
vector and assistance with generating biotinylated Gβγ. This work was
funded by National Institutes of Health Grants R01 GM078319 (to N.A.L.)
and R01 GM082892 (to D.P.S.).
1. Dohlman HG, Thorner JW (2001) Regulation of G protein-initiated signal transduction
in yeast: Paradigms and principles. Annu Rev Biochem 70:703–754.
2. Wettschureck N, Offermanns S (2005) Mammalian G proteins and their cell type
specific functions. Physiol Rev 85:1159–1204.
3. Johnston CA, Willard MD, Kimple AJ, Siderovski DP, Willard FS (2008) A sweet cycle
for Arabidopsis G-proteins: Recent discoveries and controversies in plant G-protein
signal transduction. Plant Signal Behav 3:1067–1076.
4. Gilman AG (1987) G proteins: Transducers of receptor-generated signals. Annu Rev
Biochem 56:615–649.
5. Siderovski DP, Kimple AJ, Willard FS (2008) Wiley Encyclopedia of Chemical Biology,
ed Begley T (Wiley, Hoboken, NJ).
6. Oldham WM, Van Eps N, Preininger AM, Hubbell WL, Hamm HE (2006) Mechanism of
the receptor-catalyzed activation of heterotrimeric G proteins. Nat Struct Mol Biol 13:
772–777.
7. Johnston CA, Siderovski DP (2007) Receptor-mediated activation of heterotrimeric G-
proteins: Current structural insights. Mol Pharmacol 72:219–230.
8. Digby GJ, Lober RM, Sethi PR, Lambert NA (2006) Some G protein heterotrimers
physically dissociate in living cells. Proc Natl Acad Sci USA 103:17789–17794.
9. Ross EM, Wilkie TM (2000) GTPase-activating proteins for heterotrimeric G proteins:
Regulators of G protein signaling (RGS) and RGS-like proteins. Annu Rev Biochem 69:
795–827.
10. Neubig RR, Siderovski DP (2002) Regulators of G-protein signalling as new central
nervous system drug targets. Nat Rev Drug Discov 1:187–197.
11. Tesmer JJ, Berman DM, Gilman AG, Sprang SR (1997) Structure of RGS4 bound to
AlF4—activated G(i alpha1): Stabilization of the transition state for GTP hydrolysis.
Cell 89:251–261.
12. Berman DM, Kozasa T, Gilman AG (1996) The GTPase-activating protein RGS4
stabilizes the transition state for nucleotide hydrolysis. J Biol Chem 271:27209–27212.
13. Zerangue N, Jan LY (1998) G-protein signaling: Fine-tuning signaling kinetics. Curr
Biol 8:R313–R316.
14. Doupnik CA, Davidson N, Lester HA, Kofuji P (1997) RGS proteins reconstitute the
rapid gating kinetics of gbetagamma-activated inwardly rectifying K+ channels. Proc
Natl Acad Sci USA 94:10461–10466.
15. Saitoh O, Kubo Y, Miyatani Y, Asano T, Nakata H (1997) RGS8 accelerates G-protein-
mediated modulation of K+ currents. Nature 390:525–529.
16. Willard MD, Willard FS, Siderovski DP (2008) Handbook of Cell Signaling, eds
Bradshaw R, Dennis E (Elsevier, San Diego).
17. Benians A, Nobles M, Hosny S, Tinker A (2005) Regulators of G-protein signaling form
a quaternary complex with the agonist, receptor, and G-protein. A novel explanation
for the acceleration of signaling activation kinetics. J Biol Chem 280:13383–13394.
18. Neitzel KL, Hepler JR (2006) Cellular mechanisms that determine selective RGS protein
regulation of G protein-coupled receptor signaling. Semin Cell Dev Biol 17:383–389.
19. Turcotte M, Tang W, Ross EM (2008) Coordinate regulation of G protein signaling via
dynamic interactions of receptor and GAP. PLOS Comput Biol 4:e1000148.
20. Zhong H, et al. (2003) A spatial focusing model for G protein signals. Regulator of G
protein signaling (RGS) protien-mediated kinetic scaffolding. J Biol Chem 278:
7278–7284.
21. Mukhopadhyay S, Ross EM (2002) Quench-flow kinetic measurement of individual
reactions of G-protein-catalyzed GTPase cycle. Methods Enzymol 344:350–369.
22. Thomas CJ, et al. (2004) Uncoupling conformational change from GTP hydrolysis in a
heterotrimeric G protein alpha-subunit. Proc Natl Acad Sci USA 101:7560–7565.
23. Coleman DE, et al. (1994) Structures of active conformations of Gi alpha 1 and the
mechanism of GTP hydrolysis. Science 265:1405–1412.
24. Popov S, Yu K, Kozasa T, Wilkie TM (1997) The regulators of G protein signaling (RGS)
domains of RGS4, RGS10, and GAIP retain GTPase activating protein activity in vitro.
Proc Natl Acad Sci USA 94:7216–7220.
7070 | www.pnas.org/cgi/doi/10.1073/pnas.0912934107 Lambert et al.
25. Sprang SR, Chen Z, Du X (2007) Structural basis of effector regulation and signal
termination in heterotrimeric Galpha proteins. Adv Protein Chem 74:1–65.
26. Lambright DG, Noel JP, Hamm HE, Sigler PB (1994) Structural determinants for
activation of the alpha-subunit of a heterotrimeric G protein. Nature 369:621–628.
27. Mixon MB, et al. (1995) Tertiary and quaternary structural changes in Gi alpha 1
induced by GTP hydrolysis. Science 270:954–960.
28. Noel JP, Hamm HE, Sigler PB (1993) The 2.2 A crystal structure of transducin-alpha
complexed with GTP gamma S. Nature 366:654–663.
29. Soundararajan M, et al. (2008) Structural diversity in the RGS domain and its
interaction with heterotrimeric G protein alpha-subunits. Proc Natl Acad Sci USA 105:
6457–6462.
30. Chan RK, Otte CA (1982) Physiological characterization of Saccharomyces cerevisiae
mutants supersensitive to G1 arrest by a factor and alpha factor pheromones. Mol
Cell Biol 2:21–29.
31. Chasse SA, et al. (2006) Genome-scale analysis reveals Sst2 as the principal regulator
of mating pheromone signaling in the yeast Saccharomyces cerevisiae. Eukaryot Cell
5:330–346.
32. DiBello PR, et al. (1998) Selective uncoupling of RGS action by a single point mutation
in the G protein alpha-subunit. J Biol Chem 273:5780–5784.
33. Lan KL, et al. (1998) A point mutation in Galphao and Galphai1 blocks interaction
with regulator of G protein signaling proteins. J Biol Chem 273:12794–12797.
34. Chasse SA, Dohlman HG (2004) Identification of yeast pheromone pathway
modulators by high-throughput agonist response profiling of a yeast gene knockout
strain collection. Methods Enzymol 389:399–409.
35. Hoffman GA, Garrison TR, Dohlman HG (2002) Analysis of RGS proteins in Saccharo-
myces cerevisiae.Methods Enzymol 344:617–631.
36. Hollins B, Kuravi S, Digby GJ, Lambert NA (2009) The c-terminus of GRK3 indicates
rapid dissociation of G protein heterotrimers. Cell Signal 21:1015–1021.
37. Chen H, Lambert NA (2000) Endogenous regulators of G protein signaling proteins
regulate presynaptic inhibition at rat hippocampal synapses. Proc Natl Acad Sci USA
97:12810–12815.
38. Jeong SW, Ikeda SR (2000) Endogenous regulator of G-protein signaling proteins
modify N-type calcium channel modulation in rat sympathetic neurons. J Neurosci 20:
4489–4496.
39. Arshavsky VY, Pugh EN, Jr (1998) Lifetime regulation of G protein-effector complex:
Emerging importance of RGS proteins. Neuron 20:11–14.
40. Chen CK, et al. (2000) Slowed recovery of rod photoresponse in mice lacking the
GTPase accelerating protein RGS9-1. Nature 403:557–560.
41. Sierra DA, Popov S, Wilkie TM (2000) Regulators of G-protein signaling in receptor
complexes. Trends Cardiovasc Med 10:263–268.
42. Biddlecome GH, Berstein G, Ross EM (1996) Regulation of phospholipase C-beta1 by
Gq and m1 muscarinic cholinergic receptor. Steady-state balance of receptor-
mediated activation and GTPase-activating protein-promoted deactivation. J Biol
Chem 271:7999–8007.
43. Smith B, et al. (2009) Dual positive and negative regulation of GPCR signaling by GTP
hydrolysis. Cell Signal 21:1151–1160.
44. Jaén C, Doupnik CA (2006) RGS3 and RGS4 differentially associate with G protein-
coupled receptor-Kir3 channel signaling complexes revealing two modes of RGS
modulation. Precoupling and collision coupling. J Biol Chem 281:34549–34560.
45. Mukhopadhyay S, Ross EM (1999) Rapid GTP binding and hydrolysis by G(q) promoted
by receptor and GTPase-activating proteins. Proc Natl Acad Sci USA 96:9539–9544.
46. Willard MD, et al. (2007) Selective role for RGS12 as a Ras/Raf/MEK scaffold in nerve
growth factor-mediated differentiation. EMBO J 26:2029–2040.
47. Kimple RJ, et al. (2001) RGS12 and RGS14 GoLoco motifs are G alpha(i) interaction
sites with guanine nucleotide dissociation inhibitor activity. J Biol Chem 276:
29275–29281.
48. Johnston CA, et al. (2006) Minimal determinants for binding activated G alpha from
the structure of a G alpha(i1)-peptide dimer. Biochemistry 45:11390–11400.
49. Ross EM (2002) Quantitative assays for GTPase-activating proteins. Methods Enzymol
344:601–617.
50. Sprague GF, Jr (1991) Assay of yeast mating reaction. Methods Enzymol 194:77–93.
Lambert et al. PNAS | April 13, 2010 | vol. 107 | no. 15 | 7071
PH
A
RM
A
CO
LO
G
Y
